Companies / Adial Pharmaceuticals
Adial Pharmaceuticals
United States
Adial Pharmaceuticals is developing differentiated therapies for serious immune-mediated and inflammatory diseases.
Adial Pharmaceuticals, based in United States, has 1 investor on file, among them UVA Licensing & Ventures Group.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Investor |
More from UVA Licensing & Ventures Group
35 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (61%), Industrial & Manufacturing (12%), Education (12%).
See UVA Licensing & Ventures Group's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Adial Pharmaceuticals and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when UVA Licensing & Ventures Group adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/adialpharma.com/investors
# also
GET /v1/companies/adialpharma.com
GET /v1/companies/adialpharma.com/news